Owner Avanir Pharmacueticals

Inventors Pope, Laura, E.; Katz, David, H.; Khalil, Mohammed, H.; Marchelletti, John, F.

Agent Davies Collison Cave

Pub. Number AU-B-2002360277

PCT Number PCT/US02/33019

PCT Pub. Number WO2003/032915

Priority 60/330,444 16.10.01 US

Filing date 15 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 8 March 2007

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/045 (2006.01) - Hydroxy compounds, e.g. alcohols

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics